ID
37674
Beschrijving
Study ID: 111592 Clinical Study ID: 111592 Study Title: A Randomized, Double-blind, Placebo-controlled, Doseescalation Study to Assess the Anti-inflammatory Activity, Efficacy, and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury or ARDS Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996840 See https://clinicaltrials.gov/ct2/show/NCT00996840 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Placebo, SB-681323 Trade Name: N/A Study Indication: Lung Injury, Acute The primary objective of this phase 2 trial is to evaluate the safety and tolerability of intravenous dilmapimod/SB-681323 given in escalating dosages and over different intervals for three days in trauma patients at risk for the development of ALI or ARDS. This study consists of Screening, infusion of dilmapimod/SB-681323 on days 1-3, examination/sampling up to early day 5 (denoted as "Day 3 - 48 hrs") and a Follow-up on day 7. There are four cohorts, cohorts 1 and 3 receive the medication (or placebo) infusion over 4 hours, cohorts 2 and 4 over 24 hours. This form is to be filled with data regarding pharmacodynamic results relating to the coagulation system and lung epithelial cell injury, taken repeatedly on Day 1 and 3, and can also be used for repeat analyses.
Link
https://clinicaltrials.gov/ct2/show/NCT00996840
Trefwoorden
Versies (2)
- 13-08-19 13-08-19 -
- 15-08-19 15-08-19 - Sarah Riepenhausen
Houder van rechten
GlaxoSmithKline
Geüploaded op
15 augustus 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
SB-681323 in ALI/ARDS risk patients - NCT00996840
Pharmacodynamics Results
- StudyEvent: ODM
Beschrijving
Pharmacodynamics Results
Alias
- UMLS CUI-1
- C0851347
- UMLS CUI-2
- C1254595
Beschrijving
[read-only]
Datatype
datetime
Alias
- UMLS CUI [1,1]
- C3897500
- UMLS CUI [1,2]
- C0304229
- UMLS CUI [1,3]
- C0178602
Beschrijving
Sample date/time
Datatype
datetime
Alias
- UMLS CUI [1,1]
- C0200345
- UMLS CUI [1,2]
- C1264639
- UMLS CUI [1,3]
- C0031328
Beschrijving
INR Result Type
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0525032
- UMLS CUI [1,2]
- C1274040
- UMLS CUI [1,3]
- C0332307
Beschrijving
if applicable
Datatype
float
Alias
- UMLS CUI [1,1]
- C2347373
- UMLS CUI [1,2]
- C0525032
Beschrijving
if applicable
Datatype
text
Alias
- UMLS CUI [1,1]
- C1274040
- UMLS CUI [1,2]
- C2350015
- UMLS CUI [1,3]
- C0525032
Beschrijving
PT Result Type
Datatype
integer
Alias
- UMLS CUI [1,1]
- C1274040
- UMLS CUI [1,2]
- C0332307
- UMLS CUI [1,3]
- C0491338
Beschrijving
if applicable
Datatype
float
Alias
- UMLS CUI [1,1]
- C2347373
- UMLS CUI [1,2]
- C0491338
Beschrijving
if applicable
Datatype
text
Alias
- UMLS CUI [1,1]
- C1274040
- UMLS CUI [1,2]
- C2350015
- UMLS CUI [1,3]
- C0491338
Beschrijving
PTT Result Type
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0030605
- UMLS CUI [1,2]
- C1274040
- UMLS CUI [1,3]
- C0332307
Beschrijving
if applicable
Datatype
float
Alias
- UMLS CUI [1,1]
- C2347373
- UMLS CUI [1,2]
- C0030605
Beschrijving
if applicable
Datatype
text
Alias
- UMLS CUI [1,1]
- C1274040
- UMLS CUI [1,2]
- C2350015
- UMLS CUI [1,3]
- C0030605
Similar models
Pharmacodynamics Results
- StudyEvent: ODM
C1254595 (UMLS CUI-2)
C0304229 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C1264639 (UMLS CUI [1,2])
C0031328 (UMLS CUI [1,3])
C1274040 (UMLS CUI [1,2])
C0332307 (UMLS CUI [1,3])
C0525032 (UMLS CUI [1,2])
C2350015 (UMLS CUI [1,2])
C0525032 (UMLS CUI [1,3])
C0332307 (UMLS CUI [1,2])
C0491338 (UMLS CUI [1,3])
C0491338 (UMLS CUI [1,2])
C2350015 (UMLS CUI [1,2])
C0491338 (UMLS CUI [1,3])
C1274040 (UMLS CUI [1,2])
C0332307 (UMLS CUI [1,3])
C0030605 (UMLS CUI [1,2])
C2350015 (UMLS CUI [1,2])
C0030605 (UMLS CUI [1,3])
Geen commentaren